The reality of treatment for hyperuricemia and gout in Japan: A historical cohort study using health insurance claims data

por Akari, Seigo, Nakamura, Takashi, Furusawa, Kenichi, Miyazaki, Yuichi, Kario, Kazuomi
Publicado 2022

Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice

por Nakamura, Takashi, Nampei, Mai, Murase, Takayo, Satoh, Etsuko, Akari, Seigo, Katoh, Noriaki, Mizukami, Hiroki
Publicado 2021

Systemic Endothelial Function, Plasma Xanthine Oxidoreductase Activity, and Blood Pressure Variability in Patients with Stable Coronary Artery Disease

por Hiraga, Takashi, Saito, Yuichi, Tateishi, Kazuya, Mori, Naoto, Murase, Takayo, Nakamura, Takashi, Akari, Seigo, Saito, Kan, Kitahara, Hideki, Kobayashi, Yoshio
Publicado 2022

Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention

por Sato, Ryota, Akita, Keitaro, Ikoma, Takenori, Iguchi, Keisuke, Murase, Takayo, Nakamura, Takashi, Akari, Seigo, Mogi, Satoshi, Naruse, Yoshihisa, Ohtani, Hayato, Maekawa, Yuichiro
Publicado 2021

Associations of circulating xanthine oxidoreductase activity with cardiometabolic risk markers in overweight and obese Japanese men: a cross-sectional pilot study

por Kosaki, Keisei, Yokota, Atsumu, Tanahashi, Koichiro, Myoenzono, Kanae, Park, Jiyeon, Yoshikawa, Toru, Yoshida, Yasuko, Murase, Takayo, Akari, Seigo, Nakamura, Takashi, Maeda, Seiji
Publicado 2022

The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA...

por Fujishima, Yuya, Nishizawa, Hitoshi, Kawachi, Yusuke, Nakamura, Takashi, Akari, Seigo, Ono, Yoshiyuki, Fukuda, Shiro, Kita, Shunbun, Maeda, Norikazu, Hoshide, Satoshi, Shimomura, Iichiro, Kario, Kazuomi
Publicado 2023

Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry

por Kurajoh, Masafumi, Fukumoto, Shinya, Akari, Seigo, Murase, Takayo, Nakamura, Takashi, Ihara, Yasutaka, Imai, Takumi, Nagata, Yuki, Morioka, Tomoaki, Mori, Katsuhito, Imanishi, Yasuo, Watanabe, Toshio, Emoto, Masanori
Publicado 2023

Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry

por Kurajoh, Masafumi, Fukumoto, Shinya, Yoshida, Shio, Akari, Seigo, Murase, Takayo, Nakamura, Takashi, Ishii, Haruka, Yoshida, Hisako, Nagata, Yuki, Morioka, Tomoaki, Mori, Katsuhito, Imanishi, Yasuo, Hirata, Kazuto, Emoto, Masanori
Publicado 2021

Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees

por Kurajoh, Masafumi, Fukumoto, Shinya, Akari, Seigo, Murase, Takayo, Nakamura, Takashi, Takahashi, Kanae, Yoshida, Hisako, Nakatani, Shinya, Tsuda, Akihiro, Morioka, Tomoaki, Mori, Katsuhito, Imanishi, Yasuo, Hirata, Kazuto, Emoto, Masanori
Publicado 2022

Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation

por Kawachi, Yusuke, Fujishima, Yuya, Nishizawa, Hitoshi, Nakamura, Takashi, Akari, Seigo, Murase, Takayo, Saito, Takuro, Miyazaki, Yasuhiro, Nagao, Hirofumi, Fukuda, Shiro, Kita, Shunbun, Katakami, Naoto, Doki, Yuichiro, Maeda, Norikazu, Shimomura, Iichiro
Publicado 2021

Plasma xanthine oxidoreductase activity in Japanese patients with type 2 diabetes across hospitalized treatment

por Kawachi, Yusuke, Fujishima, Yuya, Nishizawa, Hitoshi, Nagao, Hirofumi, Nakamura, Takashi, Akari, Seigo, Murase, Takayo, Taya, Naohiro, Omori, Kazuo, Miyake, Akimitsu, Fukuda, Shiro, Takahara, Mitsuyoshi, Kita, Shunbun, Katakami, Naoto, Maeda, Norikazu, Shimomura, Iichiro
Publicado 2020